OR WAIT null SECS
Massachusetts facility will support biologics developers in the New England area
PCI Pharma Services, a contract development and manufacturing organization (CDMO) and biopharma global outsourcing services provider, is opening its new Clinical Services Center of Excellence in Bridgewater, MA, a 50,000 square-foot facility that will support the growing needs of global developers of biologics in the New England region. The center will offer increased flexibility and scalability for secondary packaging, distribution, and cold chain storage of innovative therapies in development.
“As the Northeast biopharma market continues to grow, we are bringing distinctive clinical supply capabilities to the backyard of product development, creating a personalized and responsive approach to evolving client needs,” says Salim Haffar, CEO of PCI Pharma Services. “This newest facility follows our growth in facilities in Berlin, Germany, and Rockford, IL, and will create significant local job growth potential.”
To keep up with the growth in biologics and gene therapies, which require cold chain infrastructure including deep freeze, the new facility has a capacity for a -20°C freezer, 35 ultra-low temperature freezers at -80°C, and 12 liquid nitrogen freezers. The Center of Excellence also features a temperature-controlled room containing a 5,000 square-foot cooler at 2° to 8°C, each with five levels of warehouse racking. A 1000 square-foot cold secondary packaging room will eventually be converted to primary packaging, with the planned construction of an additional secondary packing unit.